Biologics

Precision-Targeted Therapy for Chronic Inflammatory Skin Conditions

Biologics are advanced medications that treat chronic inflammatory skin conditions by targeting specific components of the immune system — unlike traditional systemic treatments, which broadly suppress immune activity. They act on defined molecular pathways (cytokines such as TNF-alpha, IL-17, IL-23, IL-4/IL-13), providing targeted disease control with a more refined mechanism of action. Most commonly used for moderate-to-severe psoriasis and atopic dermatitis.

‍

Who is This For?

Suitable for individuals who:

• Have moderate-to-severe inflammatory skin conditions
• Have not responded adequately to topical or conventional systemic treatments
• Require long-term disease control
• Experience significant impact on quality of life from their skin condition

Prescribed following detailed medical assessment of disease severity, treatment history, and overall health.

‍

How it Works

Biologics selectively target key molecules driving inflammation. Depending on the medication, they may:

• Block specific cytokines (TNF-alpha, IL-17, IL-23, or IL-4/IL-13 pathways)
• Interrupt immune signalling that drives skin inflammation
• Reduce immune-mediated skin cell turnover

By focusing on precise pathways, biologics control disease activity without broadly suppressing the immune system. Their effects develop over time — reducing redness, scaling, itching, and frequency of flares.

‍

Clinically Proven Benefits

• Targeted mechanism of action
• Effective control of chronic inflammatory skin conditions
• Meaningful improvement in itching, redness, and scaling
• Reduced disease flare frequency
• Long-term treatment with ongoing monitoring
• Significant improvement in quality of life for many patients

‍

What to Expect

1. Pain level: Mild. Brief stinging at the subcutaneous injection site.
2. Downtime: None. No interruption to normal daily activities.
3. Sessions: Not one-off — administered regularly as part of ongoing disease management.
4. Session length: Injection takes a few minutes; infusion-based treatments take longer.
5. First results: Improvement may begin within weeks; significant results develop over months.
6. Frequency: Varies by medication — weekly to every few months.

‍

Before and During Treatment

Before treatment:

• Medical assessment and baseline investigations
• Screening for infections (TB, hepatitis where appropriate)
• Review of vaccination status

During treatment:

• Regular follow-up and monitoring throughout
• Prompt reporting of any signs of infection
• Adherence to prescribed treatment schedule

‍

Clinical Insight

Biologics are not stronger medications — they are precision therapies used in appropriately selected patients. They represent a shift towards evidence-based dermatology, where treatment is guided by an understanding of the immune mechanisms driving disease. The goal is sustained disease control with an appropriate balance of efficacy and safety, tailored to the individual.